Literature DB >> 25185086

Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias.

Stefano Arcangeli1, Berardino De Bari2, Filippo Alongi3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25185086     DOI： 10.1200/JCO.2014.56.3213

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

Authors:  Stefano Arcangeli; Carlo Greco
Journal:  Nat Rev Urol       Date:  2016-06-14       Impact factor: 14.432

2.  First Australian experience of treating localised prostate cancer patients with CyberKnife stereotactic radiotherapy: early PSA response, acute toxicity and quality of life.

Authors:  Ashutosh Dixit; Colin Tang; Sean Bydder; Mary-Anne Kedda; Eva Vosikova; Chrianna Bharat; Suki Gill
Journal:  J Med Radiat Sci       Date:  2017-03-08

3.  Patient-reported Quality of Life Following Stereotactic Body Radiotherapy and Conventionally Fractionated External Beam Radiotherapy Compared with Active Surveillance Among Men with Localized Prostate Cancer.

Authors:  Dominic H Moon; Ram S Basak; Deborah S Usinger; Gregg A Dickerson; David E Morris; Mark Perman; Maili Lim; Turner Wibbelsman; Jerry Chang; Zachary Crawford; James R Broughman; Paul A Godley; Ronald C Chen
Journal:  Eur Urol       Date:  2019-03-08       Impact factor: 20.096
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.